Isomaltulose VS Sucrose - Postprandial Effect on Incretin Profile and Second Meal Effect
NCT ID: NCT03806920
Last Updated: 2020-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2016-11-05
2019-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this nutritional intervention study, healthy participants and T2DM patients ingest 2 standardized meals for breakfast and lunch in combination with either sucrose or palatinose on 2 separate days. In addition, blood samples are taken to analyze markers of the carbohydrate metabolism, incretins and specific inflammation markers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Dose Effects of Isomaltulose and Sucrose on Glycaemic and Insulinemic Response
NCT04653207
The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants
NCT03020485
Effects of D-allulose (Psicose) With Sucrose Beverage on Glucose Tolerance and Insulin Level
NCT02455934
The Acute Effect of Malt Extract Versus Sucrose on the Response of Glucose and Insulin, Subjective Appetite Sensations and ad Libitum Energy Intake
NCT01615081
Effect of Artificial Sweetener (AFS) on Glucose Metabolism in Patients with Type 1 Diabetes (T1D)
NCT06315725
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In summary, this study evaluates the different postprandial effect of isomaltulose and sucrose on the incretin profile and as a determinant for the second meal effect.
In this nutritional intervention study, healthy participants and T2DM patients ingest 2 standardized meals for breakfast and lunch in combination with either sucrose or palatinose on 2 separated days. In addition, blood samples are taken to analyze markers of the carbohydrate metabolism, incretins and specific inflammation markers.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention A
Nutritional intervention in healthy subjects and T2DM subjects:
Accompanying a carbohydrate based breakfast, participants ingest either 50 g sucrose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Intervention A
Intervention B
Nutritional intervention in healthy subjects and T2DM subjects:
Accompanying a carbohydrate based breakfast, participants ingest either 50 g palatinose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Intervention B
Intervention C
Nutritional intervention in healthy subjects:
Accompanying a protein-based breakfast, participants ingest either 50 g sucrose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Intervention C
Intervention D
Nutritional intervention in healthy subjects:
Accompanying a protein-based breakfast, participants ingest either 50 g isomaltulose followed by a standardized lunch on 1 single day. In addition, blood samples are taken over 8 hours.
Intervention D
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention A
Intervention B
Intervention C
Intervention D
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* for healthy subjects: at least 1 component of the metabolic syndrom:
* Body mass index (BMI) ≥ 30 kg/m²
* Waist-hip ratio (WHR) ≥ 85 for women and ≥ 90 for men
* hypertension
* dyslipidemia
* glucose / insulin intolerance
Exclusion Criteria
* alcohol / drug abuse
* physical diseases: endocrinological, malign, serious cardiovascular diseases
* acute / chronic communicable disease
* psychic diseases
45 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beneo GmbH
INDUSTRY
German Institute of Human Nutrition
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med. Andreas F. H. Pfeiffer
Director (Dpt. Clinical Nutrition)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
German Institute of Human Nutrition
Potsdam, Brandenburg, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang J, Schafer SM, Kabisch S, Csanalosi M, Schuppelius B, Kemper M, Markova M, Meyer NMT, Pivovarova-Ramich O, Keyhani-Nejad F, Rohn S, Pfeiffer AFH. Implication of sugar, protein and incretins in excessive glucagon secretion in type 2 diabetes after mixed meals. Clin Nutr. 2023 Apr;42(4):467-476. doi: 10.1016/j.clnu.2023.02.011. Epub 2023 Feb 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PALA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.